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AID Is Required for c-myc/IgH
Chromosome Translocations In Vivo
regions by deletion of intervening sequences to produce
related clones of B cells that express different Ig iso-
types. The switching reaction is initiated by AID, an en-
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and/or DNA mismatch repair enzymes to produce a dou-Weill Medical College of Cornell University
New York, New York 10021 ble-strand DNA break that is then repaired by nonhomol-
ogous end joining (Casellas et al., 1998; Ehrenstein and5 Department of Medical Chemistry
Graduate School of Medicine Neuberger, 1999; Kim et al., 1999; Manis et al., 1998;
Rada et al., 2002; Rolink et al., 1996; Schrader et al.,Kyoto University
Kyoto 606-8501 1999, 2002; Wiesendanger et al., 2000). Double-strand
DNA breaks, which are intermediates in the CSR reac-Japan
tion, are substrates for chromosome translocation, and,
therefore, AID expression might be expected to facilitate
translocations. However, chromosome translocationsSummary
were not detected in thymic lymphomas and epithelial
tumors in transgenic mice overexpressing AID, andChromosome translocations between c-myc and im-
munoglobulin (Ig) are associated with Burkitt’s lym- transformation was attributed to increased somatic mu-
tation (Okazaki et al., 2003).phoma in humans and with pristane- and IL6-induced
plasmacytomas in mice. These translocations fre- Reciprocal translocations between IgH and a number
of different oncogenes including c-myc (Burkitt’s lym-quently involve Ig switch regions, suggesting that they
might be the result of aberrant Ig class switch recom- phoma), bcl-2 (follicular lymphoma), bcl-6 (diffuse large
cell lymphoma), and FGFR (multiple myeloma) are char-bination (CSR). However, a direct link between CSR
and chromosome translocations has not been estab- acteristic of human B cell malignancies (Kuppers and
Dalla-Favera, 2001; Leder et al., 1983; Rabbitts, 1994).lished. We have examined c-myc/IgH translocations
in IL6 transgenic mice that are mutant for activation Reciprocal translocations between c-myc and IgH are
also found in pristane- and IL6-induced murine plas-induced cytidine deaminase (AID), the enzyme that
initiates CSR. Here we report that AID is essential for the macytomas (Gauwerky and Croce, 1993; Potter and
Wiener, 1992) and were among the first cancer-associ-c-myc/IgH chromosome translocations induced by IL6.
ated chromosome translocations to be molecularly
characterized and shown to play an etiologic role in BIntroduction
cell transformation (Adams et al., 1985; Gauwerky and
Croce, 1993; Kuppers and Dalla-Favera, 2001; LederMalignant transformation is frequently associated with
genomic instability and chromosome translocations. et al., 1983; Potter and Wiener, 1992; Rabbitts, 1994).
Analysis of c-myc/IgH break points revealed that mostTwo broad categories of genes, genomic caretakers and
gatekeepers, are required to maintain genomic stability of these translocations involve Ig switch region DNA,
leading to the proposal that c-myc/IgH switch transloca-and prevent chromosome translocations (Kinzler and
Vogelstein, 1997). Caretakers are involved in DNA repair, tions result from aberrant resolution of Ig CSR-associ-
ated DNA double-stranded breaks (Adams et al., 1982,while gatekeepers regulate cell cycle progression and
cell death. Mature B lymphocytes are particularly prone 1983; Crews et al., 1982; Dalla-Favera et al., 1983; Erik-
son et al., 1983; Hamlyn and Rabbitts, 1983; Marcu et al.,to cancer-associated chromosome translocations, and
it has been postulated that genes involved in lymphocyte 1983; Stanton et al., 1983; Taub et al., 1982). However, a
direct mechanistic link between CSR and translocationsantigen receptor diversification might represent a third
class of genes that contribute to transforming events has not been established.
by inducing genomic instability.
Mature B cells undergo two distinct Ig gene diversifi- Results
cation reactions, CSR and somatic mutation. CSR is a
DNA recombination reaction that joins two Ig switch Balb/c mice are particularly susceptible to developing
pristane- or IL6-induced c-myc/IgH translocations and
associated plasmacytomas (Potter and Wiener, 1992).*Correspondence: nussen@mail.rockefeller.edu
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Figure 1. Lymphatic Hyperplasia in IL6 Transgenic Mice
(A) Appearance of hyperplastic lymph nodes in AID/IL6tg and AID/IL6tg mice plotted against time in months. The mean time to appreciable
hyperplasia was 5.4 months for AID/IL6tg, n  23, and 6.5 months for AID/IL6tg, n  19 (p  0.0074). In all cases, AID/IL6tg (open
circles) and AID/IL6tg mice (closed circles) were monitored for palpable lymph nodes over a period of 9 months. Percentage of mice
remaining free of enlarged LNs on the Y axis versus time on the X axis.
(B) Histology shows large numbers of plasmablasts in lymph nodes stained with hematoxylin and eosin.
(C) CD3 red and B220 green immunostaining of hyperplastic lymph nodes from AID/IL6tg and AID/IL6tg mice.
To determine whether AID is required for plasmacy- served for lymph node enlargement over a period of 9
months. In agreement with previous reports (Kovalchuktoma-associated c-myc/IgH switch translocations, we
produced Balb/c AID/ mice by speed congenic breed- et al., 2002; Suematsu et al., 1992), we found that 96%
of control mice developed enlarged lymph nodes by 9ing (Muramatsu et al., 2000; Wakeland et al., 1997). Flow
cytometry revealed that AID/ Balb/c mice resembled months of age, with a median of 4.7 months (Figure 1A).
Seventy-six percent of AID/IL6tg mice also developedpreviously reported AID/mice (Muramatsu et al., 2000;
see Supplemental Figure S1A at http://www.cell.com/ enlarged nodes by 9 months, but the median time to
appreciable lymphatic hyperplasia was 6.6 months (Fig-cgi/content/full/118/4/431/DC1). A well-characterized
IL6 transgene (Balb/c-IL6tg) (Kovalchuk et al., 2002; ure 1A); the mean time of disease onset in affected mice
was 5.4 months for AID/IL6tg mice (n  23) and 6.5Muramatsu et al., 2000; Suematsu et al., 1992) was intro-
duced into the Balb/c-AID/ background by crossing months for AID/IL6tg mice (n  19, p  0.0074).
Lymphoadenopathy resulted in mortality in both groupsthe two strains to produce AID/IL6tg and AID/IL6tg
mice. IL6 levels measured by ELISA and Q-PCR were of mice (mean 7.9 months for AID/IL6tg mice, n  8;
and 10.3 months for AID/IL6tg mice, n 3, p0.2084).similar in Balb/c-IL6tg, AID/IL6tg, and AID/IL6tg
mice (Suematsu et al., 1992; see Supplemental Figure Death was due to asphyxiation, or gastrointestinal ob-
struction by enlarged lymph nodes. Clonal transloca-S2 on the Cell web site).
In the absence of AID, B cells develop normally and tions were not detected by spectral karyotyping (SKY)
or chromosome 12 and 15 fluorescence in situ hybridiza-become antibody-producing plasma cells, but they fail
to undergo CSR or somatic mutation (Muramatsu et al., tion (400 cells examined, data not shown). In all cases,
lymphoid organs including spleen, inguinal, axillary, and2000; Revy et al., 2000). Absence of AID does not impair
the germinal center reaction, and AID/ mice have large mesenteric and submandibular lymph nodes were dif-
fusely enlarged and ranged in cellularity from five to 80numbers of germinal centers (Muramatsu et al., 2000).
Furthermore, AID/ mice and humans are indistinguish- times normal (10–160  106 cells AID/IL6tg, n  9, or
AID/IL6tg, n  11 mice versus 2 106 cells from wild-able from wild-type (Muramatsu et al., 2000; Revy et al.,
2000). Balb/c-IL6tg mice spontaneously develop hyper- type mice). Blinded histological examination showed hy-
perplastic lymph nodes containing numerous plas-plastic lymph nodes enriched in B cells with c-myc/IgH
translocations (Kovalchuk et al., 2002; Suematsu et al., mablasts that were indistinguishable in AID/IL6tg mice
and AID/IL6tg mice (Figure 1B; Kovalchuk et al., 2002;1992). IL6 is thought to have this effect by attenuating
apoptosis and promoting proliferation and differentia- Suematsu et al., 1992). However, as judged by CD3
and B220 immunostaining, the architecture of the lymphtion of late stage B cells (Morse et al., 1997). IL6 trans-
genic B cells that carry c-myc/IgH translocations repre- nodes was generally maintained in both types of mice
(Figure 1C). In addition, the cellular constituents of thesent preneoplastic cells that can only develop into
monoclonal plasmacytomas if transferred into Balb/c or nodes were similar in AID/IL6tg mice and AID/IL6tg
mice as determined by flow cytometry. Sixty to seventynude mice (Kovalchuk et al., 2002).
AID/IL6tg and control AID/IL6tg mice were ob- percent of all the cells in the nodes in AID/IL6tg mice
AID Induced c-myc/IgH Translocations
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Figure 2. Polyclonal Lymphoid Expansion
(A) Flow cytometry analysis of lymph node cells from AID/IL6tg and AID/IL6tg. Cells from hyperplastic lymph nodes were stained with
antibodies against T cell (CD4 and CD8), B cell (B220), switched B cell (IgG1), or germinal center (GL7) markers and analyzed by flow cytometry.
Numbers indicate percentages of cells in a given quadrant.
(B) B cells from hyperplastic lymph nodes from IL6tg mice are polyclonal. RNA was isolated from lymph nodes from two AID/IL6tg (white
bars) and two AID/IL6tg (black bars) mice, reverse transcribed, and cDNA PCR amplified with primers specific for Ig V genes. The cloned
sequences were compared to the database to assign a specific V family. Results are indicated as percentage of the expressed repertoire
on the Y axis, and V families are shown on the X axis.
and AID/IL6tg mice were T lymphocytes that ex- type mice (Table 1; Supplemental Figure S3; and Koval-
chuk et al., 2000a, 2000b). The translocations were notpressed either CD4 or CD8. The majority of the remaining
cells were B cells, which were IgG1 in the case of clonal, and independent translocations were found in
different lymph nodes assayed from the same mouseAID/IL6tg mice but IgM in AID/IL6tg mice, because
AID/ B cells cannot undergo CSR (Figure 2A; Mura- (Table 1 and Supplemental Figure S4). Dilutional analysis
revealed translocations at a frequency of 1/5  104 tomatsu et al., 2000). AID/IL6tg and AID/IL6tg lymph
nodes showed similar numbers of CD138 plasma cells, 1/1.8  103 total cells (corresponding to 1/4.5  104
to 1/1.6 103 B cells), depending on the sample assayedand there were slight increased numbers of GL7 germi-
nal center B cells in AID/IL6tg, as previously reported (Figure 3C). Sequence analysis of the cloned transloca-
tion breakpoints showed a series of unique junctionsfor AID/ mice (Muramatsu et al., 2000) (Figure 2A and
Supplemental Figure S1A). To determine whether the with varying amounts of microhomology but no dele-
tions or duplications, and there were no doublehyperplastic lymph nodes were associated with clonal
B cell expansion, we cloned and sequenced expressed breakpoints that might suggest sequential recombina-
tion (Table 2). In contrast, we found no c-myc/IgH trans-Ig genes from two AID/IL6tg and two AID/IL6tg
mice. We found that B cells from hyperplastic lymph locations on chromosome 12 or 15 in multiple hyperplas-
tic lymph node samples from nine AID/IL6tg mice.nodes from AID/IL6tg and AID/IL6tg mice expressed
a polyclonal Ig repertoire comparable to that expressed To compare B cells from similar stages of late B cell
development, we enriched CD138 plasma cells (Figureby wild-type or AID/ mice (Figure 2B and Supplemen-
tal Figure S1B). Thus, lymph node hyperplasia in AID/ 4A). We found multiple c-myc/IgH translocations in both
CD138 and CD138 fractions isolated from AID/IL6tgIL6tg and AID/IL6tg mice is not associated with mono-
clonal B cell expansion. We conclude that AID is not mice, but we could not detect translocations in
AID/IL6tg mice, regardless of the fraction analyzedrequired for the lymph node hyperplasia in response to
transgenic expression of IL6 but in the absence of AID (Figure 4B). We conclude that AID contributes to geno-
mic instability in B cells and mediates IL6-inducedhyperplasia is slightly delayed.
c-myc/IgH translocations found in IL6tg mice typically c-myc/IgH translocations in vivo.
involve Ig switch regions (mainly S or S) and the 5
untranslated region (promoter, exon 1, and intron 1) of Discussion
c-myc (Kovalchuk et al., 2002; Suematsu et al., 1992).
To determine whether AID is required for c-myc/IgH B lymphocytes are unique among higher eukaryotic cells
in that they routinely undergo two gene rearrangementtranslocations, we identified, cloned, and sequenced
derivative chromosome 12 and derivative chromosome reactions: V(D)J recombination and CSR. Both of these
reactions produce double-strand DNA break intermedi-15 translocations using PCR (Figures 3A and 3B; Koval-
chuk et al., 1997, 2000a). The selected primers can am- ates that have the potential to be aberrantly resolved as
chromosomal translocations (Honjo and Kataoka, 1978;plify translocations between a region 3 of JH4 in IgH
and c-myc (derivative chromosome 15) or between Iwasato et al., 1990; Matsuoka et al., 1990; Roth et al.,
1992a, 1992b; von Schwedler et al., 1990; Wuerffel et al.,c-myc and 5 of the Ig constant region (derivative chro-
mosome 12) (Figure 3A, Ig-5  c-myc-5 and Ig3  1997). Analysis of reciprocal chromosomal translocation
breakpoints associated with mouse and human B cellc-myc-3, respectively). In lymph node cells from 14
AID/IL6tg mice, we found translocations for either de- lymphomas implicated V(D)J recombination in the etiol-
ogy of early B and T cell cancers (Kuppers and Dalla-rivative chromosome 12 (11/14) or derivative chromo-
some 15 (12/14) or both (9/14), but no translocations Favera, 2001; Leder et al., 1983; Rabbitts, 1994), but this
has been difficult to prove because lymphocytes fail towere found in lymph node cells from nontransgenic wild-
Cell
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Figure 3. c-myc/IgH Translocations
(A) Schematic representation of the PCR
assay for c-myc/Ig translocations. Primers
used to detect translocations to chromosome
12 (myc 3  Ig 3) and chromosome 15
(myc 5  Ig 5) are depicted as horizontal
black and gray arrows, respectively. Vertical
black and gray arrows represent breakpoints
at chromosome 12 and 15, respectively (see
Table 2). (B) PCR amplification of chromo-
somal translocations. Genomic DNA ex-
tracted from hyperplastic LNs of AID/IL6tg
and AID/IL6tg mice was amplified as de-
scribed in Experimental Procedures. Results
from seven AID/ and seven AID/IL6tg
mice are shown. c-myc amplification using
the indicated primers (myc 5  myc 3) was
the loading control. (C) Quantification of chro-
mosome translocations by PCR. Serial dilu-
tions of LN DNA corresponding to 5 104–2
102 cells from one AID/IL6tg and four
AID/IL6tg mice were amplified as in (B).
Control c-myc amplifications of three differ-
ent dilutions are shown. Numbers below the
lanes indicate the absolute number of cells
amplified in the PCR reactions. B cell content
in these samples was the following: AID/,
75%; 7–6, 75%; 8–11, 80%; 11–6, 65%; and
12–3, 90%. In (B) and (C), the numbers above
the lanes indicate mouse ID number,
derChr12 indicates derivative chromosome
12, and derChr15 indicates derivative chro-
mosome 15.
develop in the absence of RAG1 or RAG2 (Mombaerts spontaneously arising B cell lymphomas (Difilippantonio
et al., 2002; Zhu et al., 2002). CSR was first implicatedet al., 1992; Shinkai et al., 1992). The only clear examples
of RAG-dependent chromosome translocations are non- in the etiology of c-myc/IgH translocations when molec-
ular cloning revealed that translocations associated withreciprocal, breakage-fusion-bridge translocations found
in mice deficient in nonhomologous end joining factors, murine plasmacytoma and human Burkitt’s lymphoma
joined c-myc to IgH switch regions (Adams et al., 1982,but these nonreciprocal translocations are not found in
AID Induced c-myc/IgH Translocations
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Table 1. c-myc/IgH Chromosomal Translocations in IL6tg Mice
derChr12 derChr15
Mouse IDa Genotypeb PCRc Transl.d PCR Transl.
7–6 AID/    
8–10 AID/    
8–10b AID/    
8–11 AID/    
8–12 AID/ — n/a  
8–16 AID/    
8–26 AID/  n/a  n/a
8–35 AID/    
10–20 AID/    ntc
10–20b AID/ — n/a  n/a
11–10 AID/ / ntc — n/a
11–13 AID/   — ntc
11–16 AID/ — n/a  
11–6 AID/    
12–3 AID/ — n/a  
12–4 AID/  n/a  n/a
6–3 AID/ — n/a / ntc
8–20 AID/ — n/a — n/a
8–29 AID/ — n/a — n/a
8–3 AID/ — ntc — ntc
8–3b AID/ — n/a — n/a
8–5 AID/ — ntc — n/a
9–4 AID/ — n/a — n/a
9–4b AID/ — n/a — n/a
9–5 AID/ — n/a — n/a
10–14 AID/ — ntc / ntc
10–14b AID/ — n/a — n/a
11–17 AID/ — n/a — ntc
DNA from 16 AID/IL6tg and 12 AID/IL6tg hyperplastic lymph nodes was analyzed by PCR (see Experimental Procedures) for the presence
of c-myc/IgH translocations on chromosomes 12 (derChr12) and 15 (derChr15).
a Mouse identifications as referred to in other parts of the text. A letter after the mouse ID denotes the analysis of an independent lymph node
from the same mouse.
b All mice were IL6tg.
c denotes a distinct PCR product, / refers to faint or not reproducible PCR amplification, and — refers to no detectable PCR product.
d Confirmed translocations by sequence analysis.  denotes PCR products with one end from the c-myc gene and one end from the Ig
gene. Breakpoint sequences from selected translocations are shown in Table 2.
ntc, c-myc/Ig translocations were not detected after cloning and sequencing. n/a, not analyzed.
1983; Crews et al., 1982; Dalla-Favera et al., 1983; Erik- 1982, 1983; Crews et al., 1982; Dalla-Favera et al., 1983;
Erikson et al., 1983; Hamlyn and Rabbitts, 1983; Marcuson et al., 1983; Hamlyn and Rabbitts, 1983; Marcu et
al., 1983; Stanton et al., 1983; Taub et al., 1982). Based et al., 1983; Stanton et al., 1983; Taub et al., 1982). Since
AID expression leads to the deamination of cytidine resi-on sequence analysis, it was proposed that these trans-
locations are the result of aberrant resolution of CSR- dues in switch DNA, and these lesions are the precursors
of the DNA double-strand breaks that lead to CSR (Pet-associated DNA double-strand breaks (Adams et al.,
Table 2. Breakpoint Sequences of AID/IL6tg Translocations
derChr.a Mouse IDb c-mycc Junctiond Ig
15 7–6 CAATCTGCGAGCCAGGACAGGACT AGTGTTTTCTATAAAAACTAAAAA
15 11–16 CTGTGCTTTTGACACTTTTCTCAA ATGCCTTTCTCCCTTGACTCAATC
12 7–6 CCCTCTCAGAGACTGGTAAGTCAG GTcAG TGAGCTGGGGTGAGCTGAGCTGAG
12 8–11 AGAGAACACAGGGAAAGACCACCA GA GCTGGGGTGAGCTGAGCTGAGCTG
12 8–16 GGAGCTCTTTTCAGGAGAGCTGAT C TGAGCTGGGCTGAGCTGGGCTGAG
15 12–3 CTGAAGGGCAGgGTTCGCCGACGC TTGGC TCAAGCCCAGCTTTGCTTACCTCA
12 8–10 CTCCAGAGCTGCCTTCTTAGGTCG C TGAGCTGGGGTGAGCTGGGCTGAG
15 8–10 CGGACGGTTGGAAGAGCCGTGTGT GC TCAGAACAGTCCAGTGTAGGCAGT
Translocation PCR products were cloned and sequenced.
a Derivative chromosome translocation.
b Mouse identification as referred to in other parts of the text.
c Sequence adjacent to the breakpoint. Sequences are given in the orientation in which they are found in the translocations; in derChr12, the
c-myc sequence is the reverse complement of the usual transcriptional orientation, and in derChr15, the Ig sequence is the reverse complement.
d Microhomology at junctions (overlapping sequences that cannot be assigned to a single sequence, c-myc, or Ig). Double breakpoints were
not detected.
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Figure 4. Analysis of c-myc/IgH Transloca-
tions in Plasma Cells
(A) Flow cytometry analysis of CD138
plasma cells (white histograms) and CD138
B cells (black histograms) purified from hy-
perplastic lymph nodes from AID/IL6tg and
AID/IL6tg mice.
(B) PCR analysis for the presence of c-myc/
IgH translocations (derChr12 and derChr15)
in CD138 and CD138 B cells from two
AID/IL6tg mice (8–26 and 12–4) and two
AID/IL6tg mice (8–29 and 8–20). The total
number of cells amplified in each of the
CD138 or CD138 samples was 5  104
cells. The number of CD138 cells was 2.9 
104 in 8–26, 2.4  104 in 12–4, 1.9  104 in
8–29, and 1.8  104 in 8–20.
ersen et al., 2001), our experiments provide a mechanis- tions. We speculate that AID induced by Epstein-Barr
virus produces the DNA double-strand breaks that servetic link between CSR and c-myc/IgH translocations and
establish a fundamental role for this enzyme in chromo- as substrates for the c-myc/IgH translocations associ-
ated with Burkitt’s lymphoma.somal translocations.
The approach used here does not exclude the possi- B lymphocytes account for 75% of lymphoid leuke-
mias and 90% of lymphomas; many of these cancers arebility of RAG-dependent translocations in IL6 transgenic
mice. However, RAG-induced translocations would be associated with chromosomal translocations (Armitage
and Longo, 2001). Our data suggest that AID, a B cell-expected to be associated with recombination signal
sequences (RSSs) in Ig V, D, or J gene segments and specific enzyme that induces DNA damage by cytidine
deamination, may account for the B cell predispositionto occur in immature B cells that express RAG. We did
not detect such translocations, and nearly all transloca- to cancer-associated chromosome translocations.
tions cloned from IL6 transgenic mice involve switch
Experimental Proceduresregions and are not RSS associated (Potter 2003; Koval-
chuk et al., 2002). We also cannot rule out the possibility
Mice and Cells
of translocations initiated by randomly occurring DNA Balb/c AID/ mice were derived from AID/ mice (Muramatsu et
damage that would occasionally involve c-myc and IgH al., 2000) by speed congenic backcrossing (Center for Inherited
Disease Research, http://www.cidr.jhmi.edu) (Wakeland et al.,switch regions. Nevertheless, our experiments show
1997). Briefly, mice were backcrossed into the wild-type Balb/cthat random c-myc/IgH translocations are much less
strain, and each generation was genotyped for 136 polymorphicfrequent than AID-dependent translocations in IL6 trans-
markers that distinguished between Balb/c and the original C57Bl/6genic mice, falling below the detection level of our
or CBA/J background strains. Mice from each generation were se-
assays. lected for subsequent breeding based on the proportion of Balb/c
AID is expressed in germinal center B cells, and most alleles they carried. Five backcross generations were required to
convert all markers to Balb/c. Balb/c IL6tgAID/ and IL6tgAID/human B cell cancers represent germinal center or post-
were monitored by weekly palpation for enlarged peripheral lymphgerminal center cells (Armitage and Longo, 2001). Unlike
nodes over a period of 9 months. All experiments with mice followedRAG, AID has no absolute sequence specificity but pref-
protocols approved by the Rockefeller University Institutional Ani-erentially targets RGYW sequences in Ig switch regions
mal Care and Use Committee. B cells from hyperplastic lymph nodes
and V region genes (Rogozin and Kolchanov, 1992). Fur- were purified by T cell depletion with anti-CD4 and anti-CD8 mi-
thermore, the Ig targeting mechanism has not been de- crobeads (Miltenyi). CD138 cells were purified using PE-conju-
gated anti-CD138 antibody (Pharmingen) and positive selection withtermined, and genes other than Ig genes, including on-
anti-PE microbeads (Miltenyi).cogenes, are mutated by AID (Mu¨schen et al., 2000;
Pasqualucci et al., 2001; Shen et al., 1998). Whether or
IL6 ELISA, Histology, and FACS Analysisnot such collateral non-Ig switch region lesions lead to
The concentration of human IL6 in transgenic mouse sera was mea-
double-strand DNA break substrates for chromosome sured with the Interleukin-6 Human Biotrak ELISA System (Amer-
translocation or mutations that might contribute to the sham Biosciences). For histology, sections of formalin-fixed hyper-
plastic lymph nodes and spleens were stained with hematoxylin andsurvival of B cells harboring translocations remains to
eosin. For immunostaining, sections of lymph nodes were fixed inbe determined.
paraformaldehyde and incubated with Cy5 conjugated anti-CD3 andIn addition to expression in germinal center B cells,
FITC-conjugated anti-B220 (Pharmingen) antibodies. For FACSAID is also induced by the Toll receptor ligand LPS
analysis, single cell suspensions were stained with fluorochrome-
and by infection with hepatitis C virus, Abelson murine conjugated anti-CD4, anti-CD8, anti-B220, anti-IgM, anti-IgG1, anti-
leukemia virus, or Epstein-Barr virus (Machida et al., CD138, or anti-GL7 (Pharmingen).
2004; Muramatsu et al., 1999, 2000; and F. Papavasiliou,
PCRpersonal communication). Many B cell lymphomas, in-
For RT-PCR, 5 g of total lymph node RNA was isolated (TRIzol,cluding Burkitt’s lymphoma, are associated with specific
Invitrogen) and reverse transcribed with oligo dT (SuperscriptII, In-pathogens. Although some of these pathogens, like Ep-
vitrogen). For real-time RT-PCR of human IL6, first-strand cDNA
stein-Barr virus, carry their own transforming genes, our was used for amplification with forward 5-AATTCGGTACATCCTC
results suggest that induction of AID may also contribute GACGG-3 and reverse 5-GGTTGTTTTCTGCCAGTGCCT-3 prim-
ers. Mouse GAPDH amplification (primers, 5-TGAAGCAGGCATCTto transformation by promoting chromosomal transloca-
AID Induced c-myc/IgH Translocations
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GAGGG-3 and 5-CGAAGGTGGAAGAGTGGGAG-3) was used as Casellas, R., Nussenzweig, A., Wuerffel, R., Pelanda, R., Reichlin,
A., Suh, H., Qin, X.F., Besmer, E., Kenter, A., Rajewsky, K., andendogenous control. PCR reactions were detected with SYBR Green
fluorogenic dye (Applied Biosystems) in an ABIPRISM 7900HT Se- Nussenzweig, M.C. (1998). Ku80 is required for immunoglobulin iso-
type switching. EMBO J. 17, 2404–2411.quence Detection System (Applied Biosystems). Relative quantifica-
tion was performed after construction of standard curves for human Crews, S., Barth, R., Hood, L., Prehn, J., and Calame, K. (1982).
IL6 and mouse GAPDH expression with serial dilutions of a calibrator Mouse c-myc oncogene is located on chromosome 15 and translo-
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